13D/13G Filings - RA Capital Management, L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, ...24, 25, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-14
5:46 pm
Purchase
2024-09-30 13G Adicet Bio, Inc.
ACET
RA Capital Management, L.P. 8,308,532
9.990%
611,583increase
(+7.95%)
Filing
History
2024-11-14
5:46 pm
Purchase
2024-09-30 13G Alto Neuroscience, Inc.
ANRO
RA Capital Management, L.P. 2,075,154
7.700%
689,663increase
(+49.78%)
Filing
History
2024-11-14
5:46 pm
Purchase
2024-09-30 13G Avidity Biosciences, Inc.
RNA
RA Capital Management, L.P. 6,300,408
5.400%
1,404,449increase
(+28.69%)
Filing
History
2024-11-14
5:46 pm
Purchase
2024-09-30 13G GH Research PLC
GHRS
RA Capital Management, L.P. 6,686,689
12.900%
1,099,356increase
(+19.68%)
Filing
History
2024-11-14
5:46 pm
Purchase
2024-09-30 13G Enliven Therapeutics, Inc.
ELVN
RA Capital Management, L.P. 1,061,233
2.200%
1,061,233increase
(New Position)
Filing
History
2024-11-14
5:46 pm
Purchase
2024-09-30 13G Rhythm Pharmaceuticals, Inc.
RYTM
RA Capital Management, L.P. 6,084,412
9.950%
754,000increase
(+14.15%)
Filing
History
2024-11-14
5:46 pm
Purchase
2024-09-30 13G Vaxcyte, Inc.
PCVX
RA Capital Management, L.P. 12,649,728
9.990%
2,964,649increase
(+30.61%)
Filing
History
2024-11-14
5:46 pm
Purchase
2024-09-30 13G Verona Pharma plc
VRNA
RA Capital Management, L.P. 8,460,090
9.990%
956,114increase
(+12.74%)
Filing
History
2024-11-13
6:04 pm
Purchase
2024-11-08 13D Tyra Biosciences, Inc.
TYRA
RA Capital Management, L.P. 10,677,140
21.100%
586,069increase
(+5.81%)
Filing
History
2024-11-12
4:15 pm
Purchase
2024-11-04 13G Bright Minds Biosciences Inc.
DRUG
RA Capital Management, L.P. 460,829
6.600%
460,829increase
(New Position)
Filing
History
2024-11-06
5:41 pm
Purchase
2024-10-30 13G GlycoMimetics, Inc.
GLYC
RA Capital Management, L.P. 6,383,000
9.900%
6,383,000increase
(New Position)
Filing
History
2024-11-06
4:15 pm
Purchase
2024-10-30 13G Ensysce Biosciences, Inc.
ENSC
RA Capital Management, L.P. 98,400
9.900%
98,400increase
(New Position)
Filing
History
2024-11-05
4:17 pm
Purchase
2024-10-29 13G Eledon Pharmaceuticals, Inc.
ELDN
RA Capital Management, L.P. 3,566,338
6.100%
3,566,338increase
(New Position)
Filing
History
2024-11-04
4:39 pm
Purchase
2024-10-28 13D Septerna, Inc.
SEPN
RA Capital Management, L.P. 6,995,858
15.800%
6,995,858increase
(New Position)
Filing
History
2024-10-31
4:17 pm
Purchase
2024-10-24 13G Monopar Therapeutics Inc.
MNPR
RA Capital Management, L.P. 511,207
9.700%
511,207increase
(New Position)
Filing
History
2024-10-22
5:11 pm
Sale
2024-10-18 13D Tyra Biosciences, Inc.
TYRA
RA Capital Management, L.P. 10,091,071
19.990%
-384,418decrease
(-3.67%)
Filing
History
2024-10-22
4:17 pm
Sale
2024-10-18 13D Janux Therapeutics, Inc.
JANX
RA Capital Management, L.P. 10,443,181
19.990%
-299,812decrease
(-2.79%)
Filing
History
2024-10-07
4:16 pm
Purchase
2024-09-27 13G BioAge Labs, Inc.
BIOA
RA Capital Management, L.P. 2,210,589
6.200%
2,210,589increase
(New Position)
Filing
History
2024-10-01
5:47 pm
Purchase
2024-09-27 13D Wave Life Sciences Ltd.
WVE
RA Capital Management, L.P. 25,414,165
16.000%
8,144,354increase
(+47.16%)
Filing
History
2024-09-23
4:17 pm
Purchase
2024-09-16 13D Bicara Therapeutics Inc. Common Stock
BCAX
RA Capital Management, L.P. 6,955,993
12.800%
6,955,993increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, ...24, 25, Next